As the smart microbial cell counters are equipped with high quality optics and sophisticated software that brings cell concentration and viability data with incredible speed, accuracy, and reliability. Smart microbial cell counter instruments are witnessing tremendous growth involved in various research activities such as cancer biology, immunology, and neuroscience, and others.  This offers lucrative growth opportunities for the smart microbial cell counters market globally.

Technological advancements acts as a burgeoning factors for the ultimate growth of global smart microbial cell counters market
With technological support, it has upsurge the development of enhanced solutions that enhance the improved image analysis by introducing new product range in the global smart microbial cell counter market. With growing focus on both inter-and intra-lab reproducibility in research, companies are now focusing on getting accurate cell counts when compared with traditional methods. The newly developed technology is highly dependent on automated cell counters by image guided technology. For instance, Logos Bio-systems image based automated cell counters provides accurate and reliable cell count. Moreover, the advanced de-clustering algorithms distinguish single cells in cluster or clumps. The company's cell counter produces accurate and reproducible cell count results with great linearity and low technical variability.

Detection of chronic disease bolsters the demand for smart microbial cell counter market

As there is high prevalence of human immunodeficiency virus (HIV) and cancer, in several countries such as China and India started adoption of advanced technology supported by smart/automated microbial cell counter. As per the American Chemical Society, cancer cells escape from tumors into the bloodstream and seed new tumors elsewhere in the body of patients. This acts troublesome as travelling cells are hard to trace as they make up from few to billions cells in the bloodstream. Currently, researchers have developed a simple method that can count cancer cells in patients’ blood in couple of hours and with a little sample preparation. The Food and Drug Administration (FDA), approved one method of counting circulating tumor cells, but it requires extensive sample preparation. In non-clinical settings, scientists use flow cytometry to count cells, but this analysis take about one day. 

Research studies fuel the demand for smart microbial cell counters

Cell counting instruments are widely being adopted in several areas of research involving cancer biology, immunology, and neuroscience, that records lucrative growth opportunity for the smart microbial cell counter market globally. The market will also record significant CAGR as blood cell counting is acts as an imperative tool for various diseases, and its adoption propels the growth of the overall market. Smart microbial cell counter are extensively used in cancer research for determining intra-tumor heterogeneity that is essential for the assessment of cancer progression. It assists in identification and determination of primary tumor, circulating tumor, & metastatic tumor that acts critical for disease monitoring & therapeutic targeting. Additionally, by utility of smart microbial cell counter helps in determining the concentration of red blood cells (RBCs), white blood cells (WBCs), platelets, and plasma that is essential for the identification of certain viruses, pathogens, and bacteria.

Segmental Analysis

The smart microbial cell counter market is segmented based on product and end-user. Based on product, the market is classified into instruments and consumables & accessories. By instruments, the market is further sub-segmented as spectrophotometers, flow cytometers, hemocytometers, automated cell counters, and others. Furthermore, consumables & accessory is further sub-segmented as reagents, micro plates, and others. By end-user, the market is segmented as hospitals & diagnostic laboratories, research & academic institutes, pharmaceutical & biotechnology companies, and others.

Based on product, Spectrophotometers holds the dominating share from the past and is projected that it will continue similar trend in the forthcoming years. Spectrophotometers have grabbed significant attention owing to well suited choice for the measurement of cell concentration. Moreover, several applications in research, therapeutics, and bio processing make the preferable choice by the researchers. Apart from that, rising acceptance of these instruments can be attributed to their ability to measure different intensities of light accurately for imaging purpose. Such factors bolster the demand for Spectrophotometers in the global market contributing the growth of smart microbial cell counters.

On the other hand, cytometers accounted second largest market share for the global smart microbial cell counters market globally. As flow cytometers is most commonly used for the diagnosis of genetic aberrations in chromosomes there is an increasing demand for early diagnosis and surging awareness responsible for penetration of cell-based assays. These acts as a prominent factor for ultimate growth of smart microbial cell counter market globally.

Regional Overview

From the past, North America holds the dominating share for the smart microbial cell counter market. This is highly supported owing to increasing prevalence of chronic diseases like cancer and HIV. This factor acts positively for the ultimatum growth of North America regional market for smart microbial cell counter. 

Asia-Pacific is anticipated to grow exponentially in the coming years by recording significant CAGR for the smart microbial cell counters market. Presence of large pool of clinical research and biopharmaceutical companies in APAC region contribute for the growth of regional market. Moreover, availability of skilled personnel, low development cost, and favorable drug development regulations acts as stimulating factors for the growth of smart microbial cell counter market in Asia-Pacific region.

Key Takeaways

In March 2017, Beckman Coulter, announced launching of upgraded version of “CytoFLEX LX” using the “CytoFLEX” flow cytometer technology.

In July 2019, Agilent, announced acquisition of BioTek. The partnership successfully unlock significant value through joint development if customer solutions.

In February 2019, Danaher, announced signing agreement with General Electric Company. The acquisition denotes acquiring of Biopharma business of GE Life Sciences. The business will establish as a standalone operating company with Danaher’s Life Science segment.

Competitive Landscape

The prominent players involved in the global smart microbial cell counters market involve Thermo Fisher Scientific Inc, Merck KGaA, PerkinElmer Inc, Olympus Corporation, General Electric Company, Becton, Dickinson and Company, Siemens Healthineers, Bio-Rad Laboratories Inc, Sysmex Corporation, and among others.

Market Segmentation

Market By Product

Instruments

•    Spectrophotometers
•    Flow Cytometers
•    Hemocytometers
•    Automated Cell Counters
•    Others

Consumables & Accessories

•    Reagents
•    Microplates
•    Others

Market By End-use

Hospitals & Diagnostic Laboratories
Research & Academic Institutes
Pharmaceutical & Biotechnology Companies
Others

Market By Geography

North America
•    U.S.
•    Canada

Europe
•    U.K.
•    Germany
•    France
•    Spain
•    Rest of Europe

Asia-Pacific
•    China
•    Japan
•    India
•    Australia
•    South Korea
•    Rest of Asia-Pacific

Latin America
•    Brazil 
•    Mexico
•    Rest of Latin America

Middle East & Africa
•    GCC
•    South Africa
•    Rest of Middle East & Africa